A detailed history of Bellecapital International Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bellecapital International Ltd. holds 2,069 shares of LLY stock, worth $1.65 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
2,069
Previous 3,088 33.0%
Holding current value
$1.65 Million
Previous $2.8 Million 34.42%
% of portfolio
0.38%
Previous 0.62%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$772.14 - $960.02 $786,810 - $978,260
-1,019 Reduced 33.0%
2,069 $1.83 Million
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $527,705 - $661,781
-728 Reduced 19.08%
3,088 $2.8 Million
Q4 2023

Jan 22, 2024

BUY
$525.19 - $619.13 $35,712 - $42,100
68 Added 1.81%
3,816 $2.22 Million
Q3 2023

Oct 17, 2023

SELL
$434.7 - $599.3 $393,838 - $542,965
-906 Reduced 19.47%
3,748 $2.01 Million
Q2 2023

Jul 07, 2023

SELL
$350.74 - $468.98 $106,975 - $143,038
-305 Reduced 6.15%
4,654 $2.18 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $77,493 - $90,295
-241 Reduced 4.63%
4,959 $1.81 Million
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $25,793 - $29,394
-87 Reduced 1.65%
5,200 $1.68 Million
Q2 2022

Jul 27, 2022

SELL
$278.73 - $327.27 $11,985 - $14,072
-43 Reduced 0.81%
5,287 $1.71 Million
Q4 2021

Jan 20, 2022

SELL
$224.85 - $279.04 $4,946 - $6,138
-22 Reduced 0.41%
5,330 $1.47 Million
Q1 2021

Apr 13, 2021

SELL
$164.32 - $212.72 $17,582 - $22,761
-107 Reduced 1.96%
5,352 $1 Million
Q4 2020

Jan 14, 2021

SELL
$130.46 - $172.63 $9,784 - $12,947
-75 Reduced 1.36%
5,459 $922,000
Q3 2020

Oct 16, 2020

BUY
$146.22 - $169.13 $62,874 - $72,725
430 Added 8.42%
5,534 $819,000
Q1 2020

Apr 24, 2020

BUY
$119.05 - $147.35 $28,095 - $34,774
236 Added 4.85%
5,104 $708,000
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $46,082 - $57,077
-431 Reduced 8.13%
4,868 $640,000
Q3 2019

Oct 22, 2019

SELL
$106.79 - $116.16 $7,475 - $8,131
-70 Reduced 1.3%
5,299 $593,000
Q2 2019

Jul 22, 2019

BUY
$110.79 - $129.32 $27,697 - $32,330
250 Added 4.88%
5,369 $595,000
Q1 2019

Apr 23, 2019

BUY
$111.31 - $131.02 $133,794 - $157,486
1,202 Added 30.69%
5,119 $664,000
Q4 2018

Feb 07, 2019

BUY
$105.9 - $118.64 $139,258 - $156,011
1,315 Added 50.54%
3,917 $453,000
Q4 2017

Feb 06, 2018

BUY
$81.94 - $87.89 $213,207 - $228,689
2,602
2,602 $220,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.